BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 23321031)

  • 1. Diabetes mellitus and increased risk of extrahepatic cholangiocarcinoma: a meta-analysis.
    Zhang LF; Zhao HX
    Hepatogastroenterology; 2013 Jun; 60(124):684-7. PubMed ID: 23321031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes mellitus and increased risk of cholangiocarcinoma: a meta-analysis.
    Jing W; Jin G; Zhou X; Zhou Y; Zhang Y; Shao C; Liu R; Hu X
    Eur J Cancer Prev; 2012 Jan; 21(1):24-31. PubMed ID: 21857525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smoking, alcohol consumption, and the risk of extrahepatic cholangiocarcinoma: a meta-analysis.
    Ye XH; Huai JP; Ding J; Chen YP; Sun XC
    World J Gastroenterol; 2013 Dec; 19(46):8780-8. PubMed ID: 24379600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a case-control study in China.
    Tao LY; He XD; Qu Q; Cai L; Liu W; Zhou L; Zhang SM
    Liver Int; 2010 Feb; 30(2):215-21. PubMed ID: 19840244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study.
    Shaib YH; El-Serag HB; Nooka AK; Thomas M; Brown TD; Patt YZ; Hassan MM
    Am J Gastroenterol; 2007 May; 102(5):1016-21. PubMed ID: 17324130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus infection and the risk of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis of 16 case-control studies.
    Li H; Hu B; Zhou ZQ; Guan J; Zhang ZY; Zhou GW
    World J Surg Oncol; 2015 Apr; 13():161. PubMed ID: 25903488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Case-control study of risk factors in cholangiocarcinoma].
    Tao LY; He XD; Cai L; Liu W; Ji WJ; Zhao L; Zhang SM
    Zhonghua Zhong Liu Za Zhi; 2009 Oct; 31(10):759-63. PubMed ID: 20021829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological survey of biomarkers of hepatitis virus in patients with extrahepatic cholangiocarcinomas.
    Qu Z; Cui N; Qin M; Wu X
    Asia Pac J Clin Oncol; 2012 Mar; 8(1):83-7. PubMed ID: 22369448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of esophageal cancer in diabetes mellitus: a meta-analysis of observational studies.
    Huang W; Ren H; Ben Q; Cai Q; Zhu W; Li Z
    Cancer Causes Control; 2012 Feb; 23(2):263-72. PubMed ID: 22094992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis.
    Clements O; Eliahoo J; Kim JU; Taylor-Robinson SD; Khan SA
    J Hepatol; 2020 Jan; 72(1):95-103. PubMed ID: 31536748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes mellitus and risk of colorectal cancer: a meta-analysis.
    Larsson SC; Orsini N; Wolk A
    J Natl Cancer Inst; 2005 Nov; 97(22):1679-87. PubMed ID: 16288121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epidemiology of cholangiocarcinoma.
    Shaib Y; El-Serag HB
    Semin Liver Dis; 2004 May; 24(2):115-25. PubMed ID: 15192785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for cholangiocarcinoma.
    Ben-Menachem T
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):615-7. PubMed ID: 17625428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus infection, diabetes mellitus, and their synergism for cholangiocarcinoma development: a case-control study in Korea.
    Lee BS; Park EC; Park SW; Nam CM; Roh J
    World J Gastroenterol; 2015 Jan; 21(2):502-10. PubMed ID: 25593465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes mellitus and risk of prostate cancer: an updated meta-analysis based on 12 case-control and 25 cohort studies.
    Zhang F; Yang Y; Skrip L; Hu D; Wang Y; Wong C; Qiu J; Lei H
    Acta Diabetol; 2012 Dec; 49 Suppl 1():S235-46. PubMed ID: 23124624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type II diabetes mellitus is associated with a reduced risk of cholangiocarcinoma in patients with biliary tract diseases.
    Tsai MS; Lee PH; Lin CL; Peng CL; Kao CH
    Int J Cancer; 2015 May; 136(10):2409-17. PubMed ID: 25348605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis.
    Zhang H; Gao C; Fang L; Zhao HC; Yao SK
    Scand J Gastroenterol; 2013 Jan; 48(1):78-87. PubMed ID: 23137049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholelithiasis and the risk of intrahepatic cholangiocarcinoma: a meta-analysis of observational studies.
    Cai H; Kong WT; Chen CB; Shi GM; Huang C; Shen YH; Sun HC
    BMC Cancer; 2015 Nov; 15():831. PubMed ID: 26526500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory bowel disease and risk of cholangiocarcinoma: evidence from a meta-analysis of population-based studies.
    Huai JP; Ding J; Ye XH; Chen YP
    Asian Pac J Cancer Prev; 2014; 15(8):3477-82. PubMed ID: 24870743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes mellitus and increased risk of biliary tract cancer: systematic review and meta-analysis.
    Ren HB; Yu T; Liu C; Li YQ
    Cancer Causes Control; 2011 Jun; 22(6):837-47. PubMed ID: 21424210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.